Apriem Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.34M | Buy |
1,719
+934
| +119% | +$728K | 0.14% | 77 |
|
|
2025
Q1 | $648K | Buy |
785
+37
| +5% | +$30.6K | 0.08% | 90 |
|
|
2024
Q4 | $577K | Sell |
748
-15
| -2% | -$11.6K | 0.07% | 101 |
|
|
2024
Q3 | $676K | Sell |
763
-48
| -6% | -$42.5K | 0.08% | 86 |
|
|
2024
Q2 | $734K | Sell |
811
-5
| -0.6% | -$4.53K | 0.09% | 85 |
|
|
2024
Q1 | $635K | Buy |
+816
| New | +$635K | 0.08% | 94 |
|
|
2017
Q2 | – | Sell |
-63
| Closed | -$5K | – | 358 |
|
|
2017
Q1 | $5K | Sell |
63
-700
| -92% | -$55.6K | ﹤0.01% | 481 |
|
|
2016
Q4 | $56K | Sell |
763
-20
| -3% | -$1.47K | 0.02% | 216 |
|
|
2016
Q3 | $63K | Buy |
783
+83
| +12% | +$6.68K | 0.02% | 203 |
|
|
2016
Q2 | $55K | Hold |
700
| – | – | 0.02% | 217 |
|
|
2016
Q1 | $50K | Sell |
700
-352
| -33% | -$25.1K | 0.02% | 194 |
|
|
2015
Q4 | $89K | Buy |
1,052
+202
| +24% | +$17.1K | 0.03% | 147 |
|
|
2015
Q3 | $71K | Buy |
850
+150
| +21% | +$12.5K | 0.03% | 165 |
|
|
2015
Q2 | $58K | Hold |
700
| – | – | 0.02% | 199 |
|
|
2015
Q1 | $51K | Hold |
700
| – | – | 0.02% | 207 |
|
|
2014
Q4 | $48K | Hold |
700
| – | – | 0.02% | 193 |
|
|
2014
Q3 | $45K | Sell |
700
-50
| -7% | -$3.21K | 0.02% | 211 |
|
|
2014
Q2 | $47K | Sell |
750
-450
| -38% | -$28.2K | 0.02% | 203 |
|
|
2014
Q1 | $71K | Hold |
1,200
| – | – | 0.03% | 182 |
|
|
2013
Q4 | $61K | Hold |
1,200
| – | – | 0.02% | 186 |
|
|
2013
Q3 | $60K | Hold |
1,200
| – | – | 0.03% | 184 |
|
|
2013
Q2 | $59K | Buy |
+1,200
| New | +$59K | 0.03% | 178 |
|